TRESSLER NICK B. (Chief Financial Officer) received a stock award from VISTAGEN THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/2/2026ACC: 0001794362-26-000004
Officer· Chief Financial Officer
Since Dec 2025
+11.71K
Net shares
Net buyer
$2.2K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
11.71K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+11.71K
Price / share
$0.19
Trade value
$2.25K
% of position
New position
6/30/2026
0.00→11.71K
Total
Net shares
+11.71K
Net value
$2.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2026 | A · Award | +11.71K | $0.19 | $2.25K | New position | 0.00 | 11.71K |
| Total | +11.71K | $2.25K | ||||||
Derivative Transactions0
No derivative transactions reported